Groowe Groowe / Newsroom / VERA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VERA News

Vera Therapeutics, Inc. Class A Common Stock

Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight

globenewswire.com
AZN NVS ABBV BMY GILD REGN VRTX BIIB JNJ MRK ARWR TAK VERA

Black Book Research Releases 2026 Hospital RCM Evaluation, Naming Top Vendors Across 49 Revenue Cycle Management Categories

accessnewswire.com
WST JPM FLYW CMG TBRG MSFT VERA VZ ORCL PRE NOW

Starting Tomorrow! C-Level Technology Leadership and the Rise of Iconic Leaders Will Shape the Conversation at HMG Strategy’s 2026 New York CISO Summit. Be a Part of It. Register Now.

globenewswire.com
MSFT PFE BAC CVS FMS OPK VERA CMCSA LH

Black Book Names 2026 Top Client-Rated Hospital & Health System Revenue Cycle Management Vendors by Category

accessnewswire.com
WST CHCO CRNC MSFT VERA ORCL PRI ENS SNOW

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
VERA

Form 8-K

sec.gov
VERA

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy

globenewswire.com
VERA

Form 8-K

sec.gov
VERA

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
VERA

Form 8-K

sec.gov
VERA